Truvada is owned by Gilead.
Truvada contains Emtricitabine; Tenofovir Disoproxil Fumarate.
Truvada has a total of 4 drug patents out of which 0 drug patents have expired.
Truvada was authorised for market use on 02 August, 2004.
Truvada is available in tablet;oral dosage forms.
Truvada can be used as treatment of hiv; method of treatment of adults infected with hiv-1; treatment of hiv-1 infection in pediatric patients 12 years of age and older, treatment of hiv infection.
The generics of Truvada are possible to be released after 13 January, 2024.
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8592397 | GILEAD | Compositions and methods for combination antiviral therapy |
Jan, 2024
(7 months from now) | |
US9457036 | GILEAD | Compositions and methods for combination antiviral therapy |
Jan, 2024
(7 months from now) | |
US9744181 | GILEAD | Compositions and methods for combination antiviral therapy |
Jan, 2024
(7 months from now) | |
US8716264 | GILEAD | Compositions and methods for combination antiviral therapy |
Jan, 2024
(7 months from now) |
Drugs and Companies using EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE ingredient
Market Authorisation Date: 02 August, 2004
Treatment: Treatment of hiv; Method of treatment of adults infected with hiv-1; Treatment of hiv-1 infection in pediatric patients 12 years of age and older; Treatment of hiv infection
Dosage: TABLET;ORAL
15
United States
8
Japan
4
Norway
4
European Union
3
Australia
3
Korea, Republic of
3
Argentina
3
China
2
EA
2
Croatia
2
Canada
2
Poland
2
Taiwan
1
Iceland
1
AP
1
Israel
1
New Zealand
1
Denmark
1
Spain
1
Austria
1
Cyprus
1
Portugal
1
Ukraine
1
Hong Kong
1
Germany
1
Mexico
1
Slovenia
1
Brazil
1
South Africa
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic